| |
nPOD Welcomes New Investigators
nPOD is pleased to welcome the following new investigators to  the project:
Akihisa Imagawa, MD, PhD
Osaka University
Histological Differences between Japanese and Western Type 1 Diabetes
Sara Michie, PhD
Stanford University
Tissue-selective Chemokines and Adhesion Molecules in Type 1 Diabetes
Jerry Nadler, MD
Eastern Virginia Medical School
12/15 Lipoxygenase Expression in Type 1 Diabetes
Suparna Sarkar, PhD and Dirk Homann, PhD
University of Colorado, Denver
Pancreatic Expression of Chemokines in Human Type 1 Diabetes
Gerald Taborsky, PhD
University of Washington
Sypathetic Neuropathy in Type 1 Diabetes
Steve Tracy, PhD
University of Nebraska
Enteroviral Infection and Type 1 Diabetes
Research Spotlight: A New Angle on the Progression of Type 1 Diabetes
Jo Spencer, Ph.D., King's College London School of Medicine
 Dr. Jo Spencer has published extensively on immune cells that reside in the gastrointestinal system, or gut. Because this organ shares many similarities with the pancreas, Dr. Spencer has brought her expertise into the field of type 1 diabetes (T1D). Dr. Spencer’s research transitioned from the field of mucosal immune cell infiltration to the field of diabetes due to the availability of tissues through the nPOD program. By examining the immune cells present in T1D pancreata, Dr. Spencer hopes to understand what role these cells have in T1D progression. Certain immune cells are seen in the pancreas in T1D patients, but only during a certain window of time during T1D onset. Dr. Spencer’s research is critical to uncovering the mechanisms of immune cells present in the pancreas during T1D onset.(story continues to the right)
|
|
nPOD Wins Poster of Distinction at NATCO Conference
Congratulations to Patrick Rowe, PhD, whose poster presentation: "Network for Pancreatic Organ Donors with Type 1 Diabetes (nPOD):  Progress and Donor Demographics" won Top Abstract/Case Study presented in a Poster Format at the NATCO 34th Annual Meeting in August, 2009. NATCO is committed to the advancement of organ and tissue donation and transplantation. Its membership is comprised of a diverse group of professionals, including procurement practitioners, transplant practitioners, hospital development specialists, and public education specialists. For more information about the organization, please visit the NATCO website.
nPOD's Scientific Advisory Board (SAB)
The nPOD Scientific Advisory Board (SAB) was appointed in July, 2009 and has subsequently held two meetings. This independent panel of experts provides oversight for the nPOD administrative core, determines high priority activities that are important to the broader type 1 diabetes research community, provides direction for the nPOD administrative staff, and advises JDRF. We are grateful to the SAB members for their volunteer service on this board.
| Ronald Gill, PhD (Chair) |
University of Alberta |
| Michael Appel, PhD (ex-officio member) |
NIDDK, National Institutes of Health |
| Ezio Bonifacio, PhD |
Technische Universitat Dresden |
| Peter Butler, MD |
University of California, Los Angeles |
| Daniel Pipeleers, MD, PhD |
Brussels Free University |
| Stephen Rich, PhD |
University of Virginia |
Research Spotlight: Jo Spencer, PhD, cont.
(story continues from the left) Thanks to the nPOD program, Dr. Spencer has access to many tissues and slides, both in the laboratory and through online banking. “It’s been a rare privilege to work with the nPOD collection, and to actually see the specimens online before receiving them,” Dr. Spencer remarked in our interview. Her research on immune cells in T1D progression provides an anatomical viewpoint and gives researchers a new way to understand this disease in humans. Ultimately the nPOD program and investigators such as Dr. Spencer will contribute to the knowledge about T1D onset and progression, and will aid the development of new therapies for T1D patients.
Interested in learning more about nPOD?
Please contact the nPOD coordinator via email at npod@pathology.ufl.edu or by phone at (352) 846-3965. |
|
